Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 73 (HNRNPA1P73) is a pseudogene derived from the functional HNRNPA1 gene, which encodes an RNA-binding protein involved in RNA processing. Pseudogenes are gene sequences that resemble functional genes but generally do not encode functional proteins due to mutations or other genomic changes[1][5]. While the parental gene (HNRNPA1) is implicated in disease and biological processes, the pseudogene HNRNPA1P73 itself does not have well-defined biological functions, disease associations, or direct therapeutic relevance. There is no evidence that HNRNPA1P73 serves as a therapeutic target, nor is it associated with drug interactions or biomarker use[1][5]. The presence of “pseudogene” in its name and the absence of assigned function or disease associations confirm its status as a non-functional genomic element[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 73 (HNRNPA1P73).